Share Price and Basic Stock Data
Last Updated: July 26, 2025, 12:05 pm
| PEG Ratio | 0.09 |
|---|
Competitors of Ind-Swift Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Lactose (India) Ltd | 140 Cr. | 99.0 | 247/84.3 | 27.0 | 41.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
| MPS Pharmaa Ltd | 4.95 Cr. | 2.59 | 4.33/2.50 | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 35.8 Cr. | 48.2 | 94.9/45.2 | 8.73 | 0.00 % | 41.5 % | 14.4 % | 10.0 | |
| Gujarat Inject (Kerala) Ltd | 34.2 Cr. | 23.3 | 29.1/13.1 | 33.5 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Industry Average | 19,318.57 Cr | 1,212.44 | 52.64 | 193.83 | 0.31% | 16.63% | 15.26% | 6.18 |
Quarterly Result
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 104.35 | 105.57 | 94.67 | 103.82 | 106.59 | 105.88 | 148.54 | 115.92 | 102.56 | 135.23 | 113.85 | 136.35 | 120.13 |
| Expenses | 92.32 | 95.59 | 89.55 | 92.77 | 88.69 | 97.93 | 130.14 | 104.78 | 98.07 | 120.74 | 110.63 | 121.94 | 112.80 |
| Operating Profit | 12.03 | 9.98 | 5.12 | 11.05 | 17.90 | 7.95 | 18.40 | 11.14 | 4.49 | 14.49 | 3.22 | 14.41 | 7.33 |
| OPM % | 11.53% | 9.45% | 5.41% | 10.64% | 16.79% | 7.51% | 12.39% | 9.61% | 4.38% | 10.72% | 2.83% | 10.57% | 6.10% |
| Other Income | 4.06 | 7.08 | 1.51 | 0.87 | 3.20 | 66.86 | 5.63 | 3.15 | 2.62 | 46.59 | 39.93 | 4.63 | 2.65 |
| Interest | 14.14 | 14.24 | 15.06 | 15.38 | 14.84 | 14.48 | 14.95 | 18.26 | 15.30 | 14.43 | 9.54 | 9.53 | 9.91 |
| Depreciation | 7.99 | 8.30 | 7.01 | 7.13 | 7.29 | 7.24 | 6.72 | 6.73 | 6.78 | 6.88 | 5.37 | 5.39 | 5.57 |
| Profit before tax | -6.04 | -5.48 | -15.44 | -10.59 | -1.03 | 53.09 | 2.36 | -10.70 | -14.97 | 39.77 | 28.24 | 4.12 | -5.50 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.61% | 0.00% | 0.00% | 0.00% |
| Net Profit | -6.04 | -5.48 | -15.44 | -10.59 | -1.03 | 53.10 | 2.36 | -10.71 | -14.97 | 37.54 | 28.24 | 4.11 | -5.50 |
| EPS in Rs | -1.12 | -1.01 | -2.85 | -1.96 | -0.19 | 9.80 | 0.44 | -1.98 | -2.76 | 6.93 | 5.21 | 0.76 | -1.02 |
Last Updated: February 28, 2025, 7:15 pm
Below is a detailed analysis of the quarterly data for Ind-Swift Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is 120.13 Cr.. The value appears to be declining and may need further review. It has decreased from 136.35 Cr. (Sep 2024) to 120.13 Cr., marking a decrease of 16.22 Cr..
- For Expenses, as of Dec 2024, the value is 112.80 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 121.94 Cr. (Sep 2024) to 112.80 Cr., marking a decrease of 9.14 Cr..
- For Operating Profit, as of Dec 2024, the value is 7.33 Cr.. The value appears to be declining and may need further review. It has decreased from 14.41 Cr. (Sep 2024) to 7.33 Cr., marking a decrease of 7.08 Cr..
- For OPM %, as of Dec 2024, the value is 6.10%. The value appears to be declining and may need further review. It has decreased from 10.57% (Sep 2024) to 6.10%, marking a decrease of 4.47%.
- For Other Income, as of Dec 2024, the value is 2.65 Cr.. The value appears to be declining and may need further review. It has decreased from 4.63 Cr. (Sep 2024) to 2.65 Cr., marking a decrease of 1.98 Cr..
- For Interest, as of Dec 2024, the value is 9.91 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.53 Cr. (Sep 2024) to 9.91 Cr., marking an increase of 0.38 Cr..
- For Depreciation, as of Dec 2024, the value is 5.57 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.39 Cr. (Sep 2024) to 5.57 Cr., marking an increase of 0.18 Cr..
- For Profit before tax, as of Dec 2024, the value is -5.50 Cr.. The value appears to be declining and may need further review. It has decreased from 4.12 Cr. (Sep 2024) to -5.50 Cr., marking a decrease of 9.62 Cr..
- For Tax %, as of Dec 2024, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00%.
- For Net Profit, as of Dec 2024, the value is -5.50 Cr.. The value appears to be declining and may need further review. It has decreased from 4.11 Cr. (Sep 2024) to -5.50 Cr., marking a decrease of 9.61 Cr..
- For EPS in Rs, as of Dec 2024, the value is -1.02. The value appears to be declining and may need further review. It has decreased from 0.76 (Sep 2024) to -1.02, marking a decrease of 1.78.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 3:38 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 570 | 417 | 308 | 263 | 270 | 289 | 330 | 356 | 398 | 411 | 502 | 515 |
| Expenses | 602 | 487 | 465 | 328 | 262 | 278 | 306 | 315 | 352 | 369 | 448 | 492 |
| Operating Profit | -32 | -70 | -157 | -65 | 8 | 11 | 23 | 41 | 45 | 42 | 54 | 23 |
| OPM % | -6% | -17% | -51% | -25% | 3% | 4% | 7% | 12% | 11% | 10% | 11% | 4% |
| Other Income | 11 | 2 | 13 | -246 | -20 | 34 | 22 | 14 | 24 | 72 | 53 | 328 |
| Interest | 77 | 40 | 19 | 16 | 7 | 3 | 29 | 52 | 57 | 60 | 63 | 39 |
| Depreciation | 26 | 39 | 36 | 36 | 35 | 34 | 34 | 33 | 32 | 29 | 27 | 24 |
| Profit before tax | -124 | -147 | -200 | -363 | -53 | 8 | -17 | -29 | -20 | 26 | 16 | 288 |
| Tax % | -7% | -2% | 0% | 0% | 1% | 0% | 15% | 1% | 2% | 0% | 14% | 2% |
| Net Profit | -116 | -145 | -200 | -364 | -54 | 8 | -19 | -30 | -20 | 26 | 14 | 283 |
| EPS in Rs | -22.95 | -28.83 | -39.71 | -67.25 | -9.99 | 1.51 | -3.53 | -5.51 | -3.70 | 4.81 | 2.63 | 52.33 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -25.00% | -37.93% | -82.00% | 85.16% | 114.81% | -337.50% | -57.89% | 33.33% | 230.00% | -46.15% | 1921.43% |
| Change in YoY Net Profit Growth (%) | 0.00% | -12.93% | -44.07% | 167.16% | 29.65% | -452.31% | 279.61% | 91.23% | 196.67% | -276.15% | 1967.58% |
Ind-Swift Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 9% |
| 3 Years: | 9% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 18% |
| 3 Years: | 33% |
| TTM: | 132% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 47% |
| 3 Years: | 18% |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: Unknown
Balance Sheet
Last Updated: July 25, 2025, 3:01 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 84 | -64 | -264 | -636 | -690 | -688 | -724 | -706 | -731 | -716 | -702 | -413 |
| Borrowings | 1,024 | 1,054 | 1,061 | 1,062 | 1,055 | 1,010 | 1,017 | 1,023 | 1,036 | 993 | 1,014 | 874 |
| Other Liabilities | 272 | 228 | 254 | 232 | 237 | 265 | 298 | 344 | 316 | 361 | 331 | 257 |
| Total Liabilities | 1,390 | 1,228 | 1,061 | 669 | 613 | 598 | 602 | 672 | 632 | 649 | 654 | 728 |
| Fixed Assets | 440 | 404 | 374 | 342 | 311 | 291 | 270 | 244 | 236 | 216 | 184 | 243 |
| CWIP | 4 | 4 | 4 | 2 | 0 | 0 | 0 | 13 | 9 | 30 | 51 | 0 |
| Investments | 45 | 45 | 45 | 44 | 44 | 41 | 24 | 70 | 64 | 54 | 1 | 6 |
| Other Assets | 900 | 775 | 638 | 281 | 258 | 267 | 308 | 344 | 323 | 349 | 418 | 480 |
| Total Assets | 1,390 | 1,228 | 1,061 | 669 | 613 | 598 | 602 | 672 | 632 | 649 | 654 | 728 |
Below is a detailed analysis of the balance sheet data for Ind-Swift Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
- For Reserves, as of Mar 2025, the value is -413.00 Cr.. The value appears to be improving (becoming less negative). It has improved from -702.00 Cr. (Mar 2024) to -413.00 Cr., marking an improvement of 289.00 Cr..
- For Borrowings, as of Mar 2025, the value is 874.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 1,014.00 Cr. (Mar 2024) to 874.00 Cr., marking a decrease of 140.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 257.00 Cr.. The value appears to be improving (decreasing). It has decreased from 331.00 Cr. (Mar 2024) to 257.00 Cr., marking a decrease of 74.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 728.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 654.00 Cr. (Mar 2024) to 728.00 Cr., marking an increase of 74.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 243.00 Cr.. The value appears strong and on an upward trend. It has increased from 184.00 Cr. (Mar 2024) to 243.00 Cr., marking an increase of 59.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 51.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 51.00 Cr..
- For Investments, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 6.00 Cr., marking an increase of 5.00 Cr..
- For Other Assets, as of Mar 2025, the value is 480.00 Cr.. The value appears strong and on an upward trend. It has increased from 418.00 Cr. (Mar 2024) to 480.00 Cr., marking an increase of 62.00 Cr..
- For Total Assets, as of Mar 2025, the value is 728.00 Cr.. The value appears strong and on an upward trend. It has increased from 654.00 Cr. (Mar 2024) to 728.00 Cr., marking an increase of 74.00 Cr..
However, the Borrowings (874.00 Cr.) are higher than the Reserves (-413.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -33.00 | -71.00 | -158.00 | -66.00 | 7.00 | 10.00 | 22.00 | 40.00 | 44.00 | -951.00 | 53.00 | -851.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 338 | 282 | 425 | 451 | 151 | 113 | 95 | 104 | 111 | 83 | 93 | 111 |
| Inventory Days | 418 | 202 | 117 | 151 | 86 | 108 | 112 | 102 | 123 | 120 | 150 | 83 |
| Days Payable | 179 | 152 | 155 | 290 | 356 | 426 | 454 | 440 | 454 | 353 | 393 | 262 |
| Cash Conversion Cycle | 577 | 331 | 387 | 311 | -119 | -206 | -246 | -234 | -220 | -149 | -150 | -68 |
| Working Capital Days | 554 | 317 | 325 | 409 | -37 | -57 | -99 | -79 | -94 | -69 | -77 | -27 |
| ROCE % | -4% | -10% | -20% | -14% | -4% | -4% | 2% | 8% | 11% | 8% | 13% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 18 | Mar 17 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 2.63 | 4.81 | -3.70 | -9.36 | -69.04 |
| Diluted EPS (Rs.) | 2.63 | 4.81 | -3.70 | -9.36 | -69.04 |
| Cash EPS (Rs.) | 7.63 | 10.10 | 2.23 | -3.60 | -60.66 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -127.54 | -130.10 | -132.99 | -125.06 | -116.26 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -127.54 | -130.10 | -132.99 | -125.06 | -116.26 |
| Revenue From Operations / Share (Rs.) | 92.73 | 75.87 | 73.43 | 49.95 | 49.33 |
| PBDIT / Share (Rs.) | 19.66 | 9.95 | 12.72 | 3.04 | -9.55 |
| PBIT / Share (Rs.) | 14.66 | 4.66 | 6.80 | -3.36 | -16.15 |
| PBT / Share (Rs.) | 3.04 | 4.81 | -3.62 | -9.85 | -67.09 |
| Net Profit / Share (Rs.) | 2.63 | 4.81 | -3.70 | -9.99 | -67.25 |
| NP After MI And SOA / Share (Rs.) | 2.63 | 4.81 | -3.70 | -9.31 | -68.81 |
| PBDIT Margin (%) | 21.20 | 13.11 | 17.32 | 6.08 | -19.35 |
| PBIT Margin (%) | 15.80 | 6.13 | 9.25 | -6.71 | -32.72 |
| PBT Margin (%) | 3.27 | 6.33 | -4.92 | -19.72 | -135.99 |
| Net Profit Margin (%) | 2.83 | 6.33 | -5.03 | -20.00 | -136.32 |
| NP After MI And SOA Margin (%) | 2.83 | 6.33 | -5.03 | -18.63 | -139.48 |
| Return on Networth / Equity (%) | -2.06 | -3.69 | 0.00 | 0.00 | 0.00 |
| Return on Capital Employeed (%) | 23.76 | -8.78 | -42.68 | -110.04 | -154.20 |
| Return On Assets (%) | 2.17 | 4.01 | -3.16 | -8.20 | -56.08 |
| Long Term Debt / Equity (X) | -1.44 | -0.55 | -0.85 | -0.98 | -1.06 |
| Total Debt / Equity (X) | -1.45 | -1.39 | -1.44 | -1.54 | -1.66 |
| Asset Turnover Ratio (%) | 0.77 | 0.64 | 0.00 | 0.42 | 0.30 |
| Current Ratio (X) | 1.07 | 0.29 | 0.33 | 0.31 | 0.33 |
| Quick Ratio (X) | 0.86 | 0.19 | 0.24 | 0.23 | 0.27 |
| Inventory Turnover Ratio (X) | 2.69 | 2.45 | 0.00 | 2.97 | 1.60 |
| Interest Coverage Ratio (X) | 1.69 | 0.90 | 1.21 | 2.33 | -3.17 |
| Interest Coverage Ratio (Post Tax) (X) | 1.23 | 0.42 | 0.63 | -2.68 | -5.41 |
| Enterprise Value (Cr.) | 1049.98 | 1018.39 | 1080.08 | 1090.67 | 1083.83 |
| EV / Net Operating Revenue (X) | 2.09 | 2.48 | 2.72 | 4.03 | 4.06 |
| EV / EBITDA (X) | 9.86 | 18.90 | 15.68 | 66.27 | -20.96 |
| MarketCap / Net Operating Revenue (X) | 0.19 | 0.09 | 0.15 | 0.14 | 0.11 |
| Price / BV (X) | -0.14 | -0.05 | -0.08 | -0.05 | -0.04 |
| Price / Net Operating Revenue (X) | 0.19 | 0.09 | 0.15 | 0.14 | 0.11 |
| EarningsYield | 0.14 | 0.66 | -0.33 | -1.29 | -12.24 |
After reviewing the key financial ratios for Ind-Swift Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 2.63. This value is below the healthy minimum of 5. It has decreased from 4.81 (Mar 23) to 2.63, marking a decrease of 2.18.
- For Diluted EPS (Rs.), as of Mar 24, the value is 2.63. This value is below the healthy minimum of 5. It has decreased from 4.81 (Mar 23) to 2.63, marking a decrease of 2.18.
- For Cash EPS (Rs.), as of Mar 24, the value is 7.63. This value is within the healthy range. It has decreased from 10.10 (Mar 23) to 7.63, marking a decrease of 2.47.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -127.54. It has increased from -130.10 (Mar 23) to -127.54, marking an increase of 2.56.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -127.54. It has increased from -130.10 (Mar 23) to -127.54, marking an increase of 2.56.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 92.73. It has increased from 75.87 (Mar 23) to 92.73, marking an increase of 16.86.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 19.66. This value is within the healthy range. It has increased from 9.95 (Mar 23) to 19.66, marking an increase of 9.71.
- For PBIT / Share (Rs.), as of Mar 24, the value is 14.66. This value is within the healthy range. It has increased from 4.66 (Mar 23) to 14.66, marking an increase of 10.00.
- For PBT / Share (Rs.), as of Mar 24, the value is 3.04. This value is within the healthy range. It has decreased from 4.81 (Mar 23) to 3.04, marking a decrease of 1.77.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 2.63. This value is within the healthy range. It has decreased from 4.81 (Mar 23) to 2.63, marking a decrease of 2.18.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 2.63. This value is within the healthy range. It has decreased from 4.81 (Mar 23) to 2.63, marking a decrease of 2.18.
- For PBDIT Margin (%), as of Mar 24, the value is 21.20. This value is within the healthy range. It has increased from 13.11 (Mar 23) to 21.20, marking an increase of 8.09.
- For PBIT Margin (%), as of Mar 24, the value is 15.80. This value is within the healthy range. It has increased from 6.13 (Mar 23) to 15.80, marking an increase of 9.67.
- For PBT Margin (%), as of Mar 24, the value is 3.27. This value is below the healthy minimum of 10. It has decreased from 6.33 (Mar 23) to 3.27, marking a decrease of 3.06.
- For Net Profit Margin (%), as of Mar 24, the value is 2.83. This value is below the healthy minimum of 5. It has decreased from 6.33 (Mar 23) to 2.83, marking a decrease of 3.50.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 2.83. This value is below the healthy minimum of 8. It has decreased from 6.33 (Mar 23) to 2.83, marking a decrease of 3.50.
- For Return on Networth / Equity (%), as of Mar 24, the value is -2.06. This value is below the healthy minimum of 15. It has increased from -3.69 (Mar 23) to -2.06, marking an increase of 1.63.
- For Return on Capital Employeed (%), as of Mar 24, the value is 23.76. This value is within the healthy range. It has increased from -8.78 (Mar 23) to 23.76, marking an increase of 32.54.
- For Return On Assets (%), as of Mar 24, the value is 2.17. This value is below the healthy minimum of 5. It has decreased from 4.01 (Mar 23) to 2.17, marking a decrease of 1.84.
- For Long Term Debt / Equity (X), as of Mar 24, the value is -1.44. This value is below the healthy minimum of 0.2. It has decreased from -0.55 (Mar 23) to -1.44, marking a decrease of 0.89.
- For Total Debt / Equity (X), as of Mar 24, the value is -1.45. This value is within the healthy range. It has decreased from -1.39 (Mar 23) to -1.45, marking a decrease of 0.06.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.77. It has increased from 0.64 (Mar 23) to 0.77, marking an increase of 0.13.
- For Current Ratio (X), as of Mar 24, the value is 1.07. This value is below the healthy minimum of 1.5. It has increased from 0.29 (Mar 23) to 1.07, marking an increase of 0.78.
- For Quick Ratio (X), as of Mar 24, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.19 (Mar 23) to 0.86, marking an increase of 0.67.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.69. This value is below the healthy minimum of 4. It has increased from 2.45 (Mar 23) to 2.69, marking an increase of 0.24.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 1.69. This value is below the healthy minimum of 3. It has increased from 0.90 (Mar 23) to 1.69, marking an increase of 0.79.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.23. This value is below the healthy minimum of 3. It has increased from 0.42 (Mar 23) to 1.23, marking an increase of 0.81.
- For Enterprise Value (Cr.), as of Mar 24, the value is 1,049.98. It has increased from 1,018.39 (Mar 23) to 1,049.98, marking an increase of 31.59.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.09. This value is within the healthy range. It has decreased from 2.48 (Mar 23) to 2.09, marking a decrease of 0.39.
- For EV / EBITDA (X), as of Mar 24, the value is 9.86. This value is within the healthy range. It has decreased from 18.90 (Mar 23) to 9.86, marking a decrease of 9.04.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.19. This value is below the healthy minimum of 1. It has increased from 0.09 (Mar 23) to 0.19, marking an increase of 0.10.
- For Price / BV (X), as of Mar 24, the value is -0.14. This value is below the healthy minimum of 1. It has decreased from -0.05 (Mar 23) to -0.14, marking a decrease of 0.09.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.19. This value is below the healthy minimum of 1. It has increased from 0.09 (Mar 23) to 0.19, marking an increase of 0.10.
- For EarningsYield, as of Mar 24, the value is 0.14. This value is below the healthy minimum of 5. It has decreased from 0.66 (Mar 23) to 0.14, marking a decrease of 0.52.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ind-Swift Ltd:
- Net Profit Margin: 2.83%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.76% (Industry Average ROCE: 16.63%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -2.06% (Industry Average ROE: 15.26%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.23
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.86
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.5 (Industry average Stock P/E: 52.64)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -1.45
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.83%
About the Company - Qualitative Analysis
Ind-Swift Ltd. is a Public Limited Listed company incorporated on 06/06/1986 and has its registered office in the State of Chandigarh, India. Company's Corporate Identification Number(CIN) is L24230CH1986PLC006897 and registration number is 006897. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 515.23 Cr. and Equity Capital is Rs. 10.83 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Pharmaceuticals | 781, Industrial Area, Phase II Chandigarh Chandigarh 160002 | companysec@indswift.com http://www.indswiftltd.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. S R Mehta | Executive Chairman |
| Mr. N R Munjal | Non Executive Director |
| Dr. Gopal Munjal | Managing Director & CEO |
| Dr. V R Mehta | Joint Managing Director |
| Mr. Himanshu Jain | Non Executive Director |
| Mr. Rishav Mehta | Non Executive Director |
| Mr. S P Sharma | Independent Director |
| Dr. V K Arora | Independent Director |
| Mr. S C Galhotra | Independent Director |
| Ms. Anoop Michra | Independent Director |
| Mr. Jagvir Singh Ahluwalia | Independent Director |
| Mr. Bhupinder Singh | Independent Director |
| Mr. Subodh Gupta | Independent Director |
| Mr. Prabhat Khurana | Independent Director |
FAQ
What is the intrinsic value of Ind-Swift Ltd?
Ind-Swift Ltd's intrinsic value (as of 27 July 2025) is 104.58 530.00% higher the current market price of 16.60, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 90.1 Cr. market cap, FY2025-2026 high/low of 34.7/12.0, reserves of -413 Cr, and liabilities of 728 Cr.
What is the Market Cap of Ind-Swift Ltd?
The Market Cap of Ind-Swift Ltd is 90.1 Cr..
What is the current Stock Price of Ind-Swift Ltd as on 27 July 2025?
The current stock price of Ind-Swift Ltd as on 27 July 2025 is 16.6.
What is the High / Low of Ind-Swift Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ind-Swift Ltd stocks is ₹34.7/12.0.
What is the Stock P/E of Ind-Swift Ltd?
The Stock P/E of Ind-Swift Ltd is 11.5.
What is the Book Value of Ind-Swift Ltd?
The Book Value of Ind-Swift Ltd is 74.3.
What is the Dividend Yield of Ind-Swift Ltd?
The Dividend Yield of Ind-Swift Ltd is 0.00 %.
What is the ROCE of Ind-Swift Ltd?
The ROCE of Ind-Swift Ltd is 11.9 %.
What is the ROE of Ind-Swift Ltd?
The ROE of Ind-Swift Ltd is %.
What is the Face Value of Ind-Swift Ltd?
The Face Value of Ind-Swift Ltd is 2.00.